NMRD Stock Overview
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Nemaura Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.089 |
52 Week High | US$1.25 |
52 Week Low | US$0.068 |
Beta | -0.096 |
1 Month Change | 2.30% |
3 Month Change | -59.36% |
1 Year Change | -89.89% |
3 Year Change | -98.81% |
5 Year Change | -99.14% |
Change since IPO | -96.44% |
Recent News & Updates
Recent updates
Nemaura Medical GAAP EPS of -$0.17
Aug 15Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M
Jun 30Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market
Mar 10Nemaura Medical (NASDAQ:NMRD) Has Debt But No Earnings; Should You Worry?
Nov 17Nemaura Medical: From Believer To Skeptic
Sep 20Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move
Jul 02Nemaura Medical rallies on 200K sugarBEAT sensors order
May 05Nemaura Medical: Lowering Glucose Levels Will Increase Share Price
Feb 03How Much Of Nemaura Medical Inc. (NASDAQ:NMRD) Do Insiders Own?
Dec 22Shareholder Returns
NMRD | US Medical Equipment | US Market | |
---|---|---|---|
7D | 21.6% | 2.3% | 0.2% |
1Y | -89.9% | 12.8% | 28.1% |
Return vs Industry: NMRD underperformed the US Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: NMRD underperformed the US Market which returned 28.8% over the past year.
Price Volatility
NMRD volatility | |
---|---|
NMRD Average Weekly Movement | 24.1% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NMRD's share price has been volatile over the past 3 months.
Volatility Over Time: NMRD's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 36 | Faz Chowdhury | https://nemauramedical.com |
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs.
Nemaura Medical Inc. Fundamentals Summary
NMRD fundamental statistics | |
---|---|
Market cap | US$2.31m |
Earnings (TTM) | -US$10.65m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs NMRD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NMRD income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$1.48m |
Gross Profit | -US$1.48m |
Other Expenses | US$9.17m |
Earnings | -US$10.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.37 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -110.2% |
How did NMRD perform over the long term?
See historical performance and comparison